Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Pulmonary Hypertension

  Free Subscription


1 Acta Cardiol Sin
1 Adv Respir Med
1 Anesth Analg
1 Cancer Med
1 Cardiol Clin
1 Circ Cardiovasc Interv
1 Circ Rep
1 Circulation
6 Clin Chest Med
1 Eur J Pharmacol
1 Front Pediatr
1 Harefuah
1 Int J Cardiol
1 Int J Cardiovasc Imaging
1 Int J Mol Med
1 J Biomech Eng
2 J Card Surg
1 J Cardiovasc Pharmacol
1 J Formos Med Assoc
1 J Investig Med High Impact Case Rep
1 J Neuroimaging
1 J Pharmacol Toxicol Methods
1 Medicine (Baltimore)
1 Mol Cell Biochem
1 PLoS One
1 Pulm Circ
1 Respiration
1 Rev Cardiovasc Med
1 Sci Transl Med
1 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Cardiol Sin

  1. LEE ML, Chang MC, Wang YM
    Ischemia and No Obstructive Coronary Artery Disease and Pulmonary Hypertension in a 16-Year-Old Girl with Unquenched Hyperthyroidism of Graves' Disease.
    Acta Cardiol Sin. 2021;37:442-448.

    Adv Respir Med

  2. PANAGIOTIDOU E, Boutou A, Kalamara E, Sourla E, et al
    Diagnosis and management of combined post- and precapillary pulmonary hypertension in a patient with multiple comorbidities.
    Adv Respir Med. 2021 Jul 16. pii: VM/OJS/J/69425. doi: 10.5603/ARM.a2021.0047.
    PubMed         Abstract available

    Anesth Analg

    Pulmonary Hypertension: Controversial and Emerging Topics.
    Anesth Analg. 2021;133:e18-e19.

    Cancer Med

  4. LEE SE, Hyun Kong J, Kim SH, Jang EJ, et al
    Change of right ventricular systolic pressure can indicate dasatinib-induced pulmonary arterial hypertension in chronic myeloid leukemia.
    Cancer Med. 2021;10:1515-1524.
    PubMed         Abstract available

    Cardiol Clin

  5. TRAVERS A, Farber HW, Sarnak MJ
    Pulmonary Hypertension in Chronic Kidney Disease.
    Cardiol Clin. 2021;39:427-434.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  6. GERGES C, Friewald R, Gerges M, Shafran I, et al
    Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Cardiovasc Interv. 2021 Jul 16:CIRCINTERVENTIONS120010243.
    PubMed         Abstract available

    Circ Rep

  7. SAKURAI S, Ukyo Y
    Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension- A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study.
    Circ Rep. 2021;3:405-413.
    PubMed         Abstract available


  8. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    PubMed         Abstract available

    Clin Chest Med

  9. STEPPAN J, Heerdt PM
    Preoperative Assessment and Perioperative Management of the Patient with Pulmonary Vascular Disease.
    Clin Chest Med. 2021;42:133-141.
    PubMed         Abstract available

  10. KEARNEY K, Kotlyar E, Lau EMT
    Pulmonary Vascular Disease as a Systemic and Multisystem Disease.
    Clin Chest Med. 2021;42:167-177.
    PubMed         Abstract available

  11. PIECHURA LM, Rinewalt DE, Mallidi HR
    Advanced Surgical and Percutaneous Approaches to Pulmonary Vascular Disease.
    Clin Chest Med. 2021;42:143-154.
    PubMed         Abstract available

  12. RAMIREZ RL 3RD, Pienkos SM, de Jesus Perez V, Zamanian RT, et al
    Pulmonary Arterial Hypertension Secondary to Drugs and Toxins.
    Clin Chest Med. 2021;42:19-38.
    PubMed         Abstract available

  13. AHARI J, Bhatnagar A, Johnson A, Gomberg-Maitland M, et al
    Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension.
    Clin Chest Med. 2021;42:125-131.
    PubMed         Abstract available

    Pulmonary Vascular Diseases Associated with Infectious Disease-Schistosomiasis and Human Immunodeficiency Viruses.
    Clin Chest Med. 2021;42:71-80.
    PubMed         Abstract available

    Eur J Pharmacol

  15. HUANG N, Zhu TT, Liu T, Ge XY, et al
    Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
    Eur J Pharmacol. 2021;908:174307.
    PubMed         Abstract available

    Front Pediatr

  16. CHEN Y, Zhang D, Li Y, Yan A, et al
    Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.
    Front Pediatr. 2021;9:695610.
    PubMed         Abstract available


    Harefuah. 2021;160:415-418.
    PubMed         Abstract available

    Int J Cardiol

  18. BARRADAS-PIRES A, Segura de la Cal T, Constantine A, Dimopoulos K, et al
    Systemic microangiopathy in Eisenmenger syndrome - The missing link?
    Int J Cardiol. 2021;337:62-63.

    Int J Cardiovasc Imaging

  19. SANNA GD, Parodi G
    Accuracy of echocardiography in pulmonary hypertension: thinking outside of the box beyond the Achilles' heel of right atrial pressure estimation.
    Int J Cardiovasc Imaging. 2021 Jul 10. pii: 10.1007/s10554-021-02345.

    Int J Mol Med

  20. JIN H, Jiao Y, Guo L, Ma Y, et al
    Astragaloside IV blocks monocrotalineinduced pulmonary arterial hypertension by improving inflammation and pulmonary artery remodeling.
    Int J Mol Med. 2021;47:595-606.
    PubMed         Abstract available

    J Biomech Eng

  21. WALTER R, Hunter K, Stenmark K, Kheyfets V, et al
    Hemodynamically Unloading the Distal Pulmonary Circulation in Pulmonary Hypertension - A Modeling Study.
    J Biomech Eng. 2021 Jul 12. pii: 1114506. doi: 10.1115/1.4051719.
    PubMed         Abstract available

    J Card Surg

  22. CERVANTES-SALAZAR JL, Garcia-Montes JA, Peralta-Santos H, Ortega-Zhindon DB, et al
    Rehabilitation of pulmonary arteries: Hybrid treatment in the unilateral absence of the pulmonary artery.
    J Card Surg. 2021;36:2970-2973.
    PubMed         Abstract available

  23. PELENGHI S, Primiceri C, Belliato M, Ghio S, et al
    Is it time for a paradigm shift: Should double-lung transplant be considered the treatment of choice for idiopathic pulmonary arterial hypertension and giant pulmonary aneurysm?
    J Card Surg. 2021;36:2996-2999.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  24. DE JESUS SILVA F, Drummond FR, Fidelis MR, Freitas MO, et al
    Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension.
    J Cardiovasc Pharmacol. 2020 Oct 9. doi: 10.1097/FJC.0000000000000928.
    PubMed         Abstract available

    J Formos Med Assoc

  25. HUNG CC, Cheng CC, Huang WC
    2018 TSOC guideline focused updated on diagnosis and treatment of pulmonary arterial hypertension.
    J Formos Med Assoc. 2021;120:1541-1542.

    J Investig Med High Impact Case Rep

  26. RAO S, Khan A, Sampat P, Sandhu M, et al
    An Uncommon Incidence of Pulmonary Hypertension Associated With Neurofibromatosis Type 1: A Case Report.
    J Investig Med High Impact Case Rep. 2021;9:23247096211032821.
    PubMed         Abstract available

    J Neuroimaging

  27. ROY B, Vacas S, Ehlert L, McCloy K, et al
    Brain Structural Changes in Patients with Pulmonary Arterial Hypertension.
    J Neuroimaging. 2021;31:524-531.
    PubMed         Abstract available

    J Pharmacol Toxicol Methods

  28. ELASSAL A, Steppan J, Charania S, Santhanam L, et al
    Pressure-based estimation of right ventricular ejection fraction: Validation as a clinically relevant target for drug development in a rodent model of pulmonary hypertension.
    J Pharmacol Toxicol Methods. 2021;112:107102.
    PubMed         Abstract available

    Medicine (Baltimore)

  29. COBRA SB, Rodrigues MP, de Melo FX, Ferreira NMC, et al
    Right ventricular contractility decreases during exercise in patients with non-advanced idiopathic pulmonary fibrosis.
    Medicine (Baltimore). 2021;100:e25915.
    PubMed         Abstract available

    Mol Cell Biochem

  30. KARTHIKA CL, Ahalya S, Radhakrishnan N, Kartha CC, et al
    Hemodynamics mediated epigenetic regulators in the pathogenesis of vascular diseases.
    Mol Cell Biochem. 2021;476:125-143.
    PubMed         Abstract available

    PLoS One

  31. FUJII S, Nagayoshi S, Ogawa K, Muto M, et al
    A pilot cohort study assessing the feasibility of complete revascularization with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    PLoS One. 2021;16:e0254770.
    PubMed         Abstract available

    Pulm Circ

  32. TANAKA TD, Ishizawar DC, Saito T, Yoshii A, et al
    Successful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report.
    Pulm Circ. 2021;11:20458940211027791.
    PubMed         Abstract available


  33. GENECAND L, Adler D, Beghetti M, Lador F, et al
    Cardiac Output Determination in Precapillary Pulmonary Hypertension: A Systematic Review.
    Respiration. 2021 Jul 13:1-8. doi: 10.1159/000517084.
    PubMed         Abstract available

    Rev Cardiovasc Med

  34. ZHANG H, Sun T, Yang J, Sun Y, et al
    Lipocalin 2: could it be a new biomarker in pediatric pulmonary hypertension associated with congenital heart disease?
    Rev Cardiovasc Med. 2021;22:531-536.
    PubMed         Abstract available

    Sci Transl Med

  35. GU M, Donato M, Guo M, Wary N, et al
    iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension.
    Sci Transl Med. 2021;13.
    PubMed         Abstract available

    Transplant Proc

  36. ABLONCZY L, Ferenci T, Somoskovi O, Osvath R, et al
    Prognostic Value of Early Risk Stratification in Pediatric Pulmonary Arterial Hypertension.
    Transplant Proc. 2021;53:1439-1442.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.